Literature DB >> 26316539

Selectivity in the Use of Gi/o Proteins Is Determined by the DRF Motif in CXCR6 and Is Cell-Type Specific.

Satya P Singh1, John F Foley1, Hongwei H Zhang1, Darrell E Hurt1, Jennifer L Richards1, Craig S Smith1, Fang Liao1, Joshua M Farber2.   

Abstract

CXCR6, the receptor for CXCL16, is expressed on multiple cell types and can be a coreceptor for human immunodeficiency virus 1. Except for CXCR6, all human chemokine receptors contain the D(3.49)R(3.50)Y(3.51) sequence, and all but two contain A(3.53) at the cytoplasmic terminus of the third transmembrane helix (H3C), a region within class A G protein-coupled receptors that contacts G proteins. In CXCR6, H3C contains D(3.49)R(3.50)F(3.51)I(3.52)V(3.53) at positions 126-130. We investigated the importance and interdependence of the canonical D126 and the noncanonical F128 and V130 in CXCR6 by mutating D126 to Y, F128 to Y, and V130 to A singly and in combination. For comparison, we mutated the analogous positions D142, Y144, and A146 to Y, F, and V, respectively, in CCR6, a related receptor containing the canonical sequences. Mutants were analyzed in both human embryonic kidney 293T and Jurkat E6-1 cells. Our data show that for CXCR6 and/or CCR6, mutations in H3C can affect both receptor signaling and chemokine binding; noncanonical H3C sequences are functionally linked, with dual changes mitigating the effects of single mutations; mutations in H3C that compromise receptor activity show selective defects in the use of individual Gi/o proteins; and the effects of mutations in H3C on receptor function and selectivity in Gi/o protein use can be cell-type specific. Our findings indicate that the ability of CXCR6 to make promiscuous use of the available Gi/o proteins is exquisitely dependent on sequences within the H3C and suggest that the native sequence allows for preservation of this function across different cellular environments. U.S. Government work not protected by U.S. copyright.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26316539      PMCID: PMC4613941          DOI: 10.1124/mol.115.099960

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  71 in total

1.  Scalable molecular dynamics with NAMD.

Authors:  James C Phillips; Rosemary Braun; Wei Wang; James Gumbart; Emad Tajkhorshid; Elizabeth Villa; Christophe Chipot; Robert D Skeel; Laxmikant Kalé; Klaus Schulten
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

Review 2.  Dimerization of chemokine receptors and its functional consequences.

Authors:  Jean-Yves Springael; Eneko Urizar; Marc Parmentier
Journal:  Cytokine Growth Factor Rev       Date:  2005-06-23       Impact factor: 7.638

Review 3.  The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state.

Authors:  G Enrico Rovati; Valérie Capra; Richard R Neubig
Journal:  Mol Pharmacol       Date:  2006-12-27       Impact factor: 4.436

4.  Charged residues of the conserved DRY triplet of the vasopressin V1a receptor provide molecular determinants for cell surface delivery and internalization.

Authors:  Stuart R Hawtin
Journal:  Mol Pharmacol       Date:  2005-07-27       Impact factor: 4.436

5.  Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis.

Authors:  Bernard Lagane; Sébastien Ballet; Thierry Planchenault; Karl Balabanian; Emmanuel Le Poul; Cédric Blanpain; Yann Percherancier; Isabelle Staropoli; Gilbert Vassart; Martin Oppermann; Marc Parmentier; Françoise Bachelerie
Journal:  Mol Pharmacol       Date:  2005-03-10       Impact factor: 4.436

6.  Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers.

Authors:  Yann Percherancier; Yamina A Berchiche; Isabelle Slight; Rudolf Volkmer-Engert; Hirokazu Tamamura; Nobutaka Fujii; Michel Bouvier; Nikolaus Heveker
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

7.  Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1,Gi2, and Gi3.

Authors:  J Robert Lane; Ben Powney; Alan Wise; Steven Rees; Graeme Milligan
Journal:  Mol Pharmacol       Date:  2007-02-07       Impact factor: 4.436

8.  Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II.

Authors:  Xavier Deupi; Patricia Edwards; Ankita Singhal; Benjamin Nickle; Daniel Oprian; Gebhard Schertler; Jörg Standfuss
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-23       Impact factor: 11.205

Review 9.  Molecular signatures of G-protein-coupled receptors.

Authors:  A J Venkatakrishnan; Xavier Deupi; Guillaume Lebon; Christopher G Tate; Gebhard F Schertler; M Madan Babu
Journal:  Nature       Date:  2013-02-14       Impact factor: 49.962

10.  G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody.

Authors:  Tomoya Hino; Takatoshi Arakawa; Hiroko Iwanari; Takami Yurugi-Kobayashi; Chiyo Ikeda-Suno; Yoshiko Nakada-Nakura; Osamu Kusano-Arai; Simone Weyand; Tatsuro Shimamura; Norimichi Nomura; Alexander D Cameron; Takuya Kobayashi; Takao Hamakubo; So Iwata; Takeshi Murata
Journal:  Nature       Date:  2012-01-29       Impact factor: 49.962

View more
  5 in total

Review 1.  'Crystal' Clear? Lysophospholipid Receptor Structure Insights and Controversies.

Authors:  Victoria A Blaho; Jerold Chun
Journal:  Trends Pharmacol Sci       Date:  2018-11       Impact factor: 14.819

2.  The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion.

Authors:  Andrea Koenen; Aaron Babendreyer; Julian Schumacher; Tobias Pasqualon; Nicole Schwarz; Anke Seifert; Xavier Deupi; Andreas Ludwig; Daniela Dreymueller
Journal:  PLoS One       Date:  2017-03-07       Impact factor: 3.240

3.  Behavior of Chemokine Receptor 6 (CXCR6) in Complex with CXCL16 Soluble form Chemokine by Molecular Dynamic Simulations: General Protein‒Ligand Interaction Model and 3D-QSAR Studies of Synthetic Antagonists.

Authors:  Giovanny Aguilera-Durán; Antonio Romo-Mancillas
Journal:  Life (Basel)       Date:  2021-04-15

4.  Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo.

Authors:  Giovanny Aguilera-Durán; Antonio Romo-Mancillas
Journal:  Molecules       Date:  2020-09-25       Impact factor: 4.411

Review 5.  The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases.

Authors:  Jan Korbecki; Karolina Bajdak-Rusinek; Patrycja Kupnicka; Patrycja Kapczuk; Donata Simińska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2021-03-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.